As of the latest Form 4 filed Jan 13, 2026.
What Lisata Therapeutics Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Newest filing first — the 25 most recent filings for LSTA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | 2026-01-09 | Imam Tariq SVP, Bus Dev, General Counsel | FTax | −513.00 | $1.97 | $1.01K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Imam Tariq, SVP, Bus Dev, General Counsel | FTax | −747.00 | $1.97 | $1.47K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Imam Tariq, SVP, Bus Dev, General Counsel | FTax | −840.00 | $1.97 | $1.65K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Imam Tariq, SVP, Bus Dev, General Counsel | FTax | −1.40K | $1.97 | $2.76K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Imam Tariq, SVP, Bus Dev, General Counsel | AAward | +15.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | FTax | −781.00 | $1.97 | $1.54K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Nisco James, SVP, Fin/Treas, Chief Actg Off | FTax | −1.14K | $1.97 | $2.24K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Nisco James, SVP, Fin/Treas, Chief Actg Off | FTax | −2.13K | $1.97 | $4.20K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Nisco James, SVP, Fin/Treas, Chief Actg Off | FTax | −2.13K | $1.97 | $4.20K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Nisco James, SVP, Fin/Treas, Chief Actg Off | AAward | +15.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Buck Kristen K EVP, R&D and CMO | FTax | −2.15K | $1.97 | $4.23K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Buck Kristen K, EVP, R&D and CMO | FTax | −3.22K | $1.97 | $6.35K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Buck Kristen K, EVP, R&D and CMO | FTax | −2.98K | $1.97 | $5.87K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Buck Kristen K, EVP, R&D and CMO | FTax | −2.98K | $1.97 | $5.87K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Buck Kristen K, EVP, R&D and CMO | AAward | +25.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Flowers Cynthia Louise Director | AAward | +30.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | BROWN GREGORY B Director | AAward | +30.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Mazzo David J President & CEO | FTax | −7.85K | $1.97 | $15.5K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Mazzo David J, President & CEO | FTax | −12.2K | $1.97 | $24.1K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Mazzo David J, President & CEO | FTax | −10.5K | $1.97 | $20.7K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Mazzo David J, President & CEO | FTax | −10.5K | $1.97 | $20.7K | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | Mazzo David J, President & CEO | AAward | +81.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | AZAB MOHAMMAD Director | AAward | +30.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | HENSON HEIDI Director | AAward | +30.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-01-13 | 2026-01-09 | KLOSK STEVEN M Director | AAward | +30.5K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also LSTA’s full analysis or the market-wide insider trading feed. The tabs above jump to LSTA’s other SEC data.
Source: SEC Form 4 filings for LSTA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.